Get the Stockscreener App
2.99
2.40%
0.07
After Hours:
2.93
-0.06
-2.01%
Health Catalyst Inc stock is traded at $2.99, with a volume of 386.50K.
It is up +2.40% in the last 24 hours and down -11.54% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$2.92
Open:
$2.92
24h Volume:
386.50K
Relative Volume:
0.58
Market Cap:
$211.49M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-1.9933
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
+26.69%
1M Performance:
-11.54%
6M Performance:
-18.75%
1Y Performance:
-65.43%
1-Day Range:
$2.92
$3.025
1-Week Range:
$2.2372
$3.025
52-Week Range:
$2.015
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.99 | 206.53M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
240.29 | 39.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
77.93 | 13.74B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
105.18 | 9.05B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
51.44 | 9.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.91 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Why Health Catalyst Inc. stock is a must watch in 2025July 2025 Short Interest & AI Forecasted Entry/Exit Points - moha.gov.vn
Can Health Catalyst Inc. stock deliver strong Q4 earnings2025 Dividend Review & Fast Gain Stock Trading Tips - BỘ NỘI VỤ
Health Catalyst and Unity Stocks Trade Up, What You Need To Know - The Globe and Mail
Health Catalyst and ON24 Stocks Trade Up, What You Need To Know - The Globe and Mail
Can Health Catalyst Inc. (2YP) stock hold up in economic slowdownQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com
Will Health Catalyst Inc. (2YP) stock gain from lower interest rates - newser.com
Unity, Wix, Upstart, Samsara, and Health Catalyst Shares Are Falling, What You Need To Know - The Globe and Mail
Why Health Catalyst Inc. stock could outperform in 2025Breakout Watch & Capital Efficient Trade Techniques - newser.com
Health Catalyst Inc. stock trend outlook and recovery pathQuarterly Earnings Summary & Intraday High Probability Setup Alerts - newser.com
Can Health Catalyst Inc. (2YP) stock sustain breakout momentumWeekly Investment Summary & Free High Return Stock Watch Alerts - newser.com
Identifying reversal signals in Health Catalyst Inc.July 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Is Health Catalyst Inc. (2YP) stock good for wealth creation2025 Stock Rankings & Daily Market Momentum Tracking - newser.com
Will Health Catalyst Inc. stock benefit from green energy trends2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
Building trade automation scripts for Health Catalyst Inc.Trade Ideas & Safe Capital Preservation Plans - newser.com
Is Health Catalyst Inc. still worth holding after the dipEarnings Growth Summary & Community Verified Watchlist Alerts - newser.com
5 Revealing Analyst Questions From Health Catalyst's Q3 Earnings Call - Finviz
Health Catalysts Q3 2025 Results: Revenue Beat, Stable Performance & 2026 OutlookNews and Statistics - IndexBox
5 Revealing Analyst Questions From Health Catalyst’s Q3 Earnings Call - The Globe and Mail
Can machine learning forecast Health Catalyst Inc. recoveryEarnings Growth Report & Expert-Curated Trade Recommendations - newser.com
Live market analysis of Health Catalyst Inc.July 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
Health Catalyst, Inc. $HCAT Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
How to build a dashboard for Health Catalyst Inc. stockPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
Why Health Catalyst Inc. stock could benefit from AI revolutionTrade Exit Report & Consistent Profit Trading Strategies - newser.com
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.28%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):